Clinical pharmacology and safety of beraprost sodium modified release (BPS-MR), an oral twice daily prostacyclin analogue-a phase II study

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2010
This article has no abstract
Epistemonikos ID: 2ed7bb83879e199d8408b98fa033959684476e82
First added on: Feb 05, 2025